Variant report
Variant | rs4694551 |
---|---|
Chromosome Location | chr4:69886460-69886461 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:40)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:40 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MBD4 | chr4:69885689-69886488 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr4:69886176-69886490 | A549 | lung: | n/a | n/a |
3 | MYBL2 | chr4:69885263-69886486 | HepG2 | liver: | n/a | n/a |
4 | FOXA1 | chr4:69885312-69886654 | HepG2 | liver: | n/a | chr4:69886249-69886264 |
5 | CEBPB | chr4:69886187-69886480 | HepG2 | liver: | n/a | n/a |
6 | FOXA2 | chr4:69885951-69886567 | A549 | lung: | n/a | n/a |
7 | CEBPB | chr4:69886177-69886484 | HepG2 | liver: | n/a | n/a |
8 | MYBL2 | chr4:69884676-69886649 | HepG2 | liver: | n/a | n/a |
9 | SP1 | chr4:69885381-69886611 | HepG2 | liver: | n/a | n/a |
10 | SP1 | chr4:69885411-69886606 | A549 | lung: | n/a | n/a |
11 | HDAC2 | chr4:69885851-69886484 | HepG2 | liver: | n/a | chr4:69886254-69886263 chr4:69886187-69886196 |
12 | JUND | chr4:69885686-69886476 | A549 | lung: | n/a | chr4:69885873-69885884 |
13 | HNF4G | chr4:69886126-69886497 | HepG2 | liver: | n/a | chr4:69886231-69886245 |
14 | FOXA1 | chr4:69885819-69886555 | HepG2 | liver: | n/a | chr4:69886249-69886264 |
15 | EP300 | chr4:69885783-69886499 | HepG2 | liver: | n/a | chr4:69886186-69886196 |
16 | RAD21 | chr4:69885857-69886512 | HepG2 | liver: | n/a | n/a |
17 | CEBPB | chr4:69885959-69886509 | HepG2 | liver: | n/a | n/a |
18 | REST | chr4:69885961-69886497 | A549 | lung: | n/a | n/a |
19 | MBD4 | chr4:69885154-69886499 | HepG2 | liver: | n/a | n/a |
20 | EP300 | chr4:69885586-69886623 | A549 | lung: | n/a | chr4:69886186-69886196 |
21 | FOXA1 | chr4:69885861-69886506 | HepG2 | liver: | n/a | chr4:69886249-69886264 |
22 | NFIC | chr4:69885693-69886626 | HepG2 | liver: | n/a | n/a |
23 | EP300 | chr4:69885558-69886725 | A549 | lung: | n/a | chr4:69886186-69886196 |
24 | FOXA2 | chr4:69885869-69886499 | HepG2 | liver: | n/a | n/a |
25 | BCL3 | chr4:69885805-69886533 | A549 | lung: | n/a | n/a |
26 | NR3C1 | chr4:69885729-69886465 | A549 | lung: | n/a | n/a |
27 | TCF12 | chr4:69885846-69886529 | HepG2 | liver: | n/a | chr4:69886254-69886263 |
28 | ARID3A | chr4:69885882-69886539 | HepG2 | liver: | n/a | n/a |
29 | FOXA2 | chr4:69885158-69886968 | HepG2 | liver: | n/a | n/a |
30 | NFIC | chr4:69885728-69886496 | HepG2 | liver: | n/a | n/a |
31 | FOXA2 | chr4:69885337-69886597 | A549 | lung: | n/a | n/a |
32 | FOSL2 | chr4:69885343-69886544 | A549 | lung: | n/a | chr4:69885872-69885883 |
33 | USF1 | chr4:69885771-69886468 | A549 | lung: | n/a | n/a |
34 | EP300 | chr4:69885877-69886502 | HepG2 | liver: | n/a | chr4:69886186-69886196 |
35 | HDAC2 | chr4:69886028-69886492 | HepG2 | liver: | n/a | chr4:69886254-69886263 chr4:69886187-69886196 |
36 | GATA3 | chr4:69885676-69886607 | A549 | lung: | n/a | n/a |
37 | TEAD4 | chr4:69885018-69886553 | HepG2 | liver: | n/a | n/a |
38 | SP1 | chr4:69885254-69886648 | A549 | lung: | n/a | n/a |
39 | TCF12 | chr4:69885345-69886681 | A549 | lung: | n/a | chr4:69886254-69886263 |
40 | FOXA1 | chr4:69885332-69886532 | HepG2 | liver: | n/a | chr4:69886249-69886264 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000251685 | TF binding region |
rs_ID | r2[population] |
---|---|
rs10006595 | 0.87[EUR][1000 genomes] |
rs10012215 | 0.80[ASN][1000 genomes] |
rs10012607 | 0.81[ASN][1000 genomes] |
rs10019619 | 0.88[AFR][1000 genomes];0.85[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs10030220 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs11249520 | 0.91[AFR][1000 genomes];0.95[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs11725519 | 0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12501837 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs12509175 | 0.91[AMR][1000 genomes];0.94[EUR][1000 genomes] |
rs12512098 | 0.88[EUR][1000 genomes] |
rs13102620 | 0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13108709 | 0.80[AFR][1000 genomes];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs13116752 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13127081 | 0.94[AMR][1000 genomes];0.93[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13128177 | 0.83[EUR][1000 genomes] |
rs13140844 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13145165 | 0.93[AFR][1000 genomes];0.86[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs13145304 | 0.85[AFR][1000 genomes];0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs13147569 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13147648 | 0.87[AMR][1000 genomes];0.93[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1841055 | 0.88[EUR][1000 genomes] |
rs1902923 | 0.83[EUR][1000 genomes] |
rs2011000 | 0.82[EUR][1000 genomes] |
rs2292524 | 0.81[AMR][1000 genomes] |
rs2331627 | 0.88[AFR][1000 genomes];0.86[AMR][1000 genomes];0.88[EUR][1000 genomes] |
rs28386872 | 0.90[EUR][1000 genomes] |
rs4235106 | 1.00[AFR][1000 genomes];0.96[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4235108 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs4235111 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4235112 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4299665 | 0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4299666 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4304032 | 1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4305590 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs4312824 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4351079 | 0.81[ASN][1000 genomes] |
rs4353969 | 0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4365792 | 0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4377650 | 0.81[ASN][1000 genomes] |
rs4422474 | 0.81[ASN][1000 genomes] |
rs4440295 | 0.92[AFR][1000 genomes];0.97[AMR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4495114 | 0.90[AMR][1000 genomes];0.93[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4518318 | 0.80[ASN][1000 genomes] |
rs4591680 | 0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs4607293 | 0.81[ASN][1000 genomes] |
rs4694490 | 0.87[EUR][1000 genomes] |
rs4694491 | 0.88[EUR][1000 genomes] |
rs4694588 | 0.81[ASN][1000 genomes] |
rs6422321 | 0.81[ASN][1000 genomes] |
rs6827511 | 0.92[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6828317 | 0.88[EUR][1000 genomes] |
rs6831147 | 0.82[EUR][1000 genomes] |
rs6837000 | 0.83[EUR][1000 genomes] |
rs6839405 | 0.83[EUR][1000 genomes] |
rs6843788 | 0.88[EUR][1000 genomes] |
rs7435274 | 0.80[ASN][1000 genomes] |
rs7438808 | 0.81[ASN][1000 genomes] |
rs7441736 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs7673174 | 0.85[EUR][1000 genomes] |
rs7691258 | 0.85[EUR][1000 genomes] |
rs7691445 | 0.85[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1005513 | chr4:69446718-69890307 | Enhancers Active TSS Weak transcription Strong transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 27 gene(s) | inside rSNPs | diseases |
2 | nsv999654 | chr4:69661415-70132110 | Weak transcription Enhancers Active TSS Flanking Active TSS Strong transcription Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
3 | esv3420586 | chr4:69680878-70322918 | Enhancers Active TSS ZNF genes & repeats Weak transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 41 gene(s) | inside rSNPs | diseases |
4 | nsv1067773 | chr4:69718248-70715727 | ZNF genes & repeats Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 49 gene(s) | inside rSNPs | diseases |
5 | esv3468151 | chr4:69718675-70322776 | Enhancers Strong transcription Active TSS Flanking Active TSS ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
6 | esv3468153 | chr4:69718675-70322776 | Enhancers Flanking Active TSS Active TSS Weak transcription Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
7 | nsv829962 | chr4:69786869-69910283 | Weak transcription Flanking Active TSS Enhancers ZNF genes & repeats Active TSS Strong transcription Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
8 | nsv594582 | chr4:69827340-69988378 | Weak transcription Enhancers Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
9 | esv2757064 | chr4:69863174-69901607 | Weak transcription Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Genic enhancers Active TSS | TF binding regionChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
10 | nsv980213 | chr4:69870183-69893292 | Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS ZNF genes & repeats Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
11 | nsv879379 | chr4:69878929-69987249 | Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats Strong transcription Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 8 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69885800-69887000 | Weak transcription | A549 | lung |
2 | chr4:69885800-69887200 | Enhancers | Fetal Intestine Large | intestine |
3 | chr4:69886000-69889000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
4 | chr4:69886000-69889800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
5 | chr4:69886000-69891000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
6 | chr4:69886200-69889200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr4:69886200-69889400 | Enhancers | Liver | Liver |
8 | chr4:69886200-69889800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr4:69886200-69893000 | Enhancers | HepG2 | liver |